Today’s AI Top Pick: ADMA

7/2/2026 · Reliable Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Reliable Bullish Consensus Deep RotationADMABUY NOW9.1 / 107/2/2026

ADMA is the cleanest 'deep rotation with confirmation' setup in the pool. Fundamentals are exceptional for a name that has been beaten down -52.8% YTD and -51.85% over one year: PE 12.7, fwdPe 8.94, PEG 0.31, ROE 43.3%, profit margin 32.43%, operating margin 40.57%, debt/equity 0.52, and analyst target upside of 106.2%. Fundamental_score 8/8, recom 1.75, bullish_prob 1.0. This is a rare mix of value AND high-quality profitability sitting deep in a drawdown — exactly the setup this screen is built for. The forecast tape confirms across timeframes without being extended. Position in weekly 21-bar range is just 8.73% (near the low, dd -46.09%), so you are NOT chasing. Yet the daily is already reclaiming: 1d recent +11.86%, 1d fc_short +57.35%, 1d fc_mid +62.32%, 1d fc_long +47.35%. The 4h shows fc_mid +77.27% and fc_long +108.39% — those are massive mid/long magnitudes with 4h dd only -1.87%. The weekly forecast (+31.75% long) confirms a base is forming, RSI 51.42 is neutral (not overbought), and daily position 92.93% shows momentum turning. The only wobble is 1h fc_short -5.71%, which is a normal pause after +11.86% on the daily — a helpful pullback for entry, not a broken thesis. News is neutral-to-positive: MarketBeat flagged ADMA as a biotech with 'major potential catalysts in the coming months,' and the recent Zacks pieces are noise, not damage. There is no guidance cut, no dilution, no short-seller report — the landmine check is clean. Compare that with the runner-ups: MNSO has equally strong fundamentals but carries Chinese ADR overhang; PODD is already at 100% of its 4h/1d range (chasing); VNT has an explicit 'reasons VNT is risky' write-up; CPNG has a live U.S.–Korea regulatory headline. ADMA has no such offset. Buying TODAY makes sense because you're getting a 4h/1d forecast breakout while the weekly still shows position 8.7% of range — the tape has confirmed short-term direction but hasn't yet re-rated the longer timeframe. Waiting means paying up after the weekly base completes.

Entry zone

$8.40–$8.75 (buy into 1h weakness given fc_short -5.71%; current $8.68)

Stop loss

$7.85 (below the 1wk 21-bar low area and ~10% below entry — invalidates the 4h/1d base)

First target

$10.20 (about +17%, aligns with 4h fc_mid trajectory and prior consolidation shelf)

Longer target

$13.50–$14.00 (about +55–60%, aligns with 1d fc_mid +62% and analyst target upside 106%)

Risks

Biotech single-product concentration (plasma-derived IG franchise); any supply/manufacturing hiccup can gap the stock 10%+
1h fc_short -5.71% signals near-term chop — poor entry timing can cost 3–5% before the trade works
Short float 9.45% could squeeze either way; on bad tape it accelerates downside
Weekly drawdown of -46% means overhead supply is heavy; a rejection at $10 zone is a realistic scenario
Sales YoY only +10.99% — deceleration from prior quarters could pressure the growth multiple

Honorable mentions

MNSOSame setup profile — PEG 0.16, fwdPe 7.69, recom 1.19, salesYoY 30.5%, RSI 42, weekly position 10%. Multi-TF forecasts strong (1d fc_short +44%, 4h fc_mid +60%). Only reason it's #2: Chinese ADR regulatory overhang and lower profit margin than ADMA (9.06% vs 32.43%).

PODDStrongest fundamental score with 1d fc +28.9% short / +58% mid and recom 1.41, but position_in_range is 100% on both 4h and 1d — you're chasing, not rotating. Better as BUY_PULLBACK.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ADMA	BUY NOW	9.1	Deep-value biotech at 8.7% of weekly range with 4h fc_long +108% and clean news — textbook rotation entry.
2	MNSO	BUY NOW	8.7	PEG 0.16, RSI 42, weekly pos 10%, 1d fc_short +44% — held back only by China ADR risk.
3	PODD	BUY PULLBACK	7.9	Strong fundamentals and 1d fc +58% mid, but 4h/1d at 100% of range — wait for a pullback into $150s.
4	TRMB	BUY NOW	7.7	Recom 1.31, targetUpside 59.9%, 1d fc_short +12% with dd -4.83% — reasonable entry, not extended.
5	WAY	BUY PULLBACK	7.4	Great fundamentals but 1h/4h/1d all at 100% range and 1h fc_short -10.68% — pullback likely.
6	QTWO	BUY NOW	7.2	1d fc_short +16.7%, fc_mid +24%, weekly pos still 68% but multi-TF alignment solid.
7	KRMN	BUY PULLBACK	7.1	Defense tailwinds and 4h fc_long +51.9%, but PE 242 and all TFs at 100% range.
8	MELI	BUY NOW	7.0	Multi-TF alignment, salesYoY 42%, ROE 31%, but 1d already at 100% — mid-conviction.
9	NICE	BUY PULLBACK	6.9	fwdPe 7.49, D/E 0.02, weekly fc_long +99% — but 1h/1d at 100% range.
10	FIGR	WAIT	6.7	Great margins but no bullish_prob data, no weekly TF, and hourly fc_short -11.97%.
11	PNR	BUY NOW	6.6	Recent Zacks upgrade to Buy, 1d fc_short +11.17% with weekly pos 17%.
12	VNT	WAIT	6.4	Screen passes but 'reasons VNT is risky' article and 1h/4h pos at 0% — falling knife risk.
13	GEHC	BUY NOW	6.3	Steady, weekly fc_long +31%, fundamentals solid — but modest magnitudes.
14	ABT	BUY NOW	6.3	Legal overhang cleared (DOJ ends formula probe), 1d fc_mid +25%, low-vol name.
15	KVYO	BUY PULLBACK	6.2	1wk fc_mid +90%, but 1h fc_short -9.32% and 1h/4h/1d all 100% of range.
16	TSCO	BUY NOW	6.1	Weekly dd -44.7%, 1d fc_short +28%, ROE 45.5% — DA Davidson lowered PT is a small cloud.
17	ITRI	BUY PULLBACK	6.0	Multi-TF alignment but PEG 3.49 and 1h/1d at 100% range.
18	NIQ	WAIT	5.9	4h fc_long +120% but negative ROE -62%, D/E 4.17, no weekly TF confirmation.
19	TTEK	BUY PULLBACK	5.7	Weekly dd -20% and $49M Army contract catalyst, but PEG 2.54 and near range highs.
20	TRI	WAIT	5.5	Weekly fc_long +74% but near_term_bullish only 0.4 and Wells Fargo just lowered PT.
21	REGN	BUY PULLBACK	5.4	FDA PreCheck positive, but near_term_bullish 0.4 and 1h/4h at low range position.
22	CHYM	BUY PULLBACK	5.3	Recently upgraded, +11% pop, but ROE -80%, no PE, no weekly TF.
23	LOPE	WAIT	5.2	Recom 1.00 is best in class, but weekly fc all negative and near_term_bullish 0.4.
24	ALC	WAIT	5.2	PE 40, PEG 1.23, only single-digit forecast magnitudes and 1h pos 7%.
25	WING	AVOID	5.1	1h fc_mid -13.83%, PE 43, all TFs at 100% range — chasing a top.
26	MDT	WAIT	5.0	Low forecast magnitudes (1d fc_mid +7%) and near_term_bullish only from 1 TF.
27	STNE	WAIT	4.8	PE 4.4 looks cheap but salesYoY -33.91% and operMargin -106% — quality broken.
28	BETA	WAIT	4.6	President selling 45K shares, negative EPS forecast, and null fundamentals block.
29	XP	WAIT	4.5	Bullish_prob only 0.6, near_term_bullish 0.2, 1d fc_long +0.36% — signal too soft.
30	CPNG	AVOID	4.0	Active U.S. House / South Korea regulatory headline landmine — pass regardless of forecast.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord